New intellectual disability diagnoses in autistic young adults: A path for staying Medicaid-enrolled?

Annual Probability of ID Accrual Graph

Adjusted annual probability of acquiring an ID diagnosis by Medicaid enrollment disruption status among autistic Medicaid beneficiaries during 2008–2016. CREDIT Meghan Carey, Drexel University

Autistic individuals often rely on Medicaid for insurance, but the transition to adulthood can, and often does, impact their enrollment status. In continuing to examine how autistic individuals use Medicaid, recent research from Drexel University’s A.J. Drexel Autism Institute has identified a trend in intellectual disability diagnoses among autistic young people that is likely indicative of a system-wide problem that makes it difficult for them to maintain coverage into adulthood.

It’s estimated that one in three autistic people use Medicaid, with nearly 70% of the enrollees being children. During the transition to adulthood, autistic young adults’ coverage can be disrupted for many reasons. At age 19, autistic young adults are reassessed for Medicaid eligibility as an individual — rather than being allowed to continue coverage as part of their family. At age 21 most states terminate autism support resources provided by the education system, which can also disrupt Medicaid access. And most states don’t have autism-specific eligibility criteria included in their Medicaid waivers, and most states that do have autism-specific eligibility criteria only cover children.  This means people whose only medical diagnosis is autism may not be eligible to continue Medicaid coverage as an adult.

Medicaid’s waiver system is currently set up to allow tailored health care services for individuals diagnosed with an intellectual disability through their transition to adulthood. Intellectual and developmental disabilities are a larger class of conditions, including autism, which is characterized by its social-behavioral differences and repetitive or restricted behaviors. The Centers for Disease Control and Prevention (CDC) uses the term intellectual disability when there are limits to a person’s ability to learn and function in daily life. For the vast majority of individuals diagnosed with autism or intellectual disability, those diagnoses are made in childhood – typically by age 8.

Previous research has found that during the transition to adulthood, autistic individuals are more likely than their non-autistic peers with intellectual disability to lose their Medicaid benefits and not re-enroll. To examine this more closely, the Drexel team decided to look at whether autistic young people who experienced disenrollment from Medicaid were actually more likely than autistic young people who had not experienced disenrollment to be diagnosed with intellectual disability in adulthood.  

Led by Meghan Carey, a doctoral student in the Epidemiology and Biostatistics department in the Dornsife School of Public Health, the research team examined national Medicaid claims data from the 2008–2016 to study the probability of autistic young people, who did not have an intellectual disability diagnosis in their first year of Medicaid enrollment, receiving an intellectual disability diagnosis later.

“We found that one in five autistic individuals, ages 8-25, received an intellectual disability diagnosis during follow-up,” said Carey. She also noted that while the co-occurrence of intellectual disability among the autistic population enrolled in Medicaid is common – about 25% – intellectual disability is most often diagnosable in early childhood, especially as children enter school when cognitive testing is delivered more frequently.

“We would expect the number of accrued intellectual disability diagnoses after age 8 to be substantially lower than the observed 19%,” said Carey. “Further, the American Psychological Association suggests any newly acquired intellectual disability after age 18 should be diagnosed as a neurocognitive disorder or another diagnosis, unless there was a traumatic brain injury, which is inconsistent with the peaks of intellectual disability accrual at ages 19 and 21 observed in this study.”

Because most states don’t have autism-specific criteria for Medicaid eligibility, Carey noted the research team hypothesized, and found, that autistic individuals who experience disruptions in Medicaid coverage – or periods of disenrollment – would be more likely accrue an intellectual disability diagnosis later, because in their home state, their autism diagnosis alone was potentially insufficient for retaining Medicaid coverage.

“New intellectual disability diagnoses may help autistic youth with coverage disruptions regain – or when receiving a diagnosis proactively, retain – Medicaid coverage and allow for continued health care service access,” said Carey. “However, it may also mean that autistic young people are no longer receiving services related to their autism diagnosis, which could have negative effects on their health.”

Carey and her coauthors hope that this research strengthens the call to ensure lifelong Medicaid coverage for autistic people.

One solution to this problem, the team suggests, would be to adjust Medicaid waivers. A change to states’ waivers that ensures adequate coverage for autistic people without a co-occurring intellectual disability diagnosis, and ensures continuity in coverage through adulthood, could be an effective approach to mitigate these disruptions to Medicaid coverage — and the need for people to be reexamined for intellectual disability diagnoses in young adulthood, according to the research team.

“Their service needs don’t just end when they become adults,” said Carey. “Given Medicaid is a critical safety net insurer and the lifelong needs of autistic individuals, policies aimed at ensuring Medicaid coverage continues from childhood throughout adulthood are essential to meet the health care-related needs for autistic people.”

Autistic siblings share more of dad’s genome, not mum’s

Parental genome sharing among siblings with autism

CAPTION

For decades, Cold Spring Harbor Laboratory scientists and collaborators have invested millions of dollars into deciphering the genetic causes of autism Cold Spring Harbor Laboratory

Cold Spring Harbor Laboratory (CSHL) researchers have flipped the script on autism ) genetics.

Scientists long thought that siblings born with autism share more of their mother’s genome than their father’s. But CSHL Associate Professor Ivan Iossifov and Professor Michael Wigler have now shown that, in many cases, it’s dad who might be playing a bigger genetic role.

Autism spectrum disorders cover a range of neurological and developmental conditions. They can affect how a person communicates, socializes, learns, and behaves. Autism may also manifest as repetitive behaviors or restricted interests. In the United States, it affects around one in 36 children. 

“There are children diagnosed with autism who are high functioning,” Iossifov says. “They have a completely productive life, although they have some minor troubles in social interactions, as most of us do. But also, there are children diagnosed with autism who never learn to speak, and they have definitely a difficult life.”

Over the last two decades, CSHL scientists have led a multimillion-dollar effort to uncover the genetic origins of autism. They discovered thousands of genes that, when damaged, may cause a child to be born with autism. But their work was not able to account for all cases of autism. So Iossifov and Wigler set out to find the missing sources.

The duo analyzed the genomes of over 6,000 volunteer families. They found that in families that have two or more children with autism, the siblings shared more of their father’s genome. Meanwhile, in families where only one sibling had autism , the children shared less of their father’s genome. While the discovery reveals a new potential source of autism, it also poses a provocative question. Could other disorders play by the same genetic rules?

No one is sure how dad’s genome makes its mark on children with autism. But Iossifov has a couple interesting ideas. He thinks some fathers may carry protective mutations that fail to get passed on. Or fathers may pass down mutations that trigger the mother’s immune system to attack the developing embryo. Both theories offer hope for parents of children with autism .

“Our future research is exciting,” Iossifov says. “If one of those theories or two of them prove to be true, then it opens different treatment strategies, which can, in the future, affect quite a lot of families.”

In addition, this research offers helpful tools for educators and therapists. It may allow for earlier diagnoses and a better overall understanding of autism.

Autism – A novel approach that stimulates cells’ DNA repair mechanisms may combat a leading cause of Fragile X

The likelihood of receiving an autism diagnosis may depend on where you live

Key Takeaways

  • Researchers have discovered that stimulating cells’ DNA repair mechanisms may correct the inherited genetic defect that defines fragile X syndrome, a leading cause of autism spectrum disorders.
  • The method involves enhanced production of special nucleic acid structures called “R-loops” that cells see as DNA damage.

BOSTON – New research has identified a potential method for treating fragile X syndrome, a leading cause of autism spectrum disorders that is characterized by an inherited repeat of certain nucleotides within the DNA sequence of the FMR1 gene. The work, which was conducted by investigators at Massachusetts General Hospital (MGH), is published in the journal Cell.

FXS is caused by an expansion of the trinucleotide repeat CGG within FMR1, which stands for Fragile X Messenger Ribonucleoprotein 1. FMR1 makes a protein called FMRP that is needed for brain development, but the CGG expansion in people born with FXS leads to reduced expression of this protein, leading to developmental delays, learning disabilities, and social and behavior problems. The disorder affects 1 in 3,000 boys and 1 in 6,000 girls.

“We wondered if we could treat FXS by contracting the trinucleotide repeat in FMR1 and restoring FMRP expression,” explains senior author Jeannie T. Lee, MD, PhD, a molecular biologist at MGH and a professor of Genetics at Harvard Medical School. “While the industry is trying to restore expression by gene therapy and gene editing, our approach was to contract the CGG repeat and restore protein expression by stimulating the body’s own DNA repair mechanisms.”

By generating models derived from the cells of patients with FXS and exposing the models to different laboratory conditions, Lee and postdoctoral fellow and first author, Hun-Goo Lee, PhD, discovered conditions that induce a strong repeat contraction and full FMR1 reactivation. The conditions required the presence of inhibitors of two kinases called MEK and BRAF. Inhibiting these enzymes led to enhanced production of special nucleic acid structures called “R-loops” formed between DNA and RNA, which cells see as DNA damage and therefore trigger repair mechanisms to fix the problem. The cells’ repair mechanisms then excise the expanded CGG repeats to achieve more normal CGG levels, enabling cells to re-express the crucial FMR1 gene.

“Because the disease is caused by the expanded CGG repeat, contracting the repeat through R-loop formation is potentially a one-and-done treatment,” says Lee. “We are now extending the technology to patient neurons and to the brain in animal models.”

The acute problem of chronic disease

Green Mitochondria

Mitochondria (green) within a cell are depicted in this colorized transmission electron micrograph. The folds are called cristae, and are where chemical reactions occur that produce energy for cellular and metabolic functions. CREDIT Thomas Deerinck, National center for Microscopy and Imaging Research, UC San DIego

In a wide-ranging paper, a UC San Diego physician-scientist explains why all chronic diseases, from diabetes to autism, are linked by the underlying failure of cells and the body to heal completely

In medicine and science, the term “pathogenesis” describes the origin and development of disease. There is not, however, a broadly accepted term to describe the other half of the equation: the process of healing and recovery.

In a new and far-reaching paper, published May 10, 2023 in the journal MitochondrionRobert K. Naviaux, MD, PhD, professor of Medicine, Pediatrics and Pathology at UC San Diego School of Medicine, proposes both a term and, more importantly, outlines the array of processes and players, beginning with cellular mitochondria, that drive the healing process – and whose dysfunction underlies chronic illnesses from diabetes and autoimmune disorders to long COVID and autism spectrum disorder. 

“Great strides in medicine since World War II have focused on and addressed the triggers and risk factors of disease,” said Naviaux. “This pathogenesis-based approach has been very effective in developing treatments for acute illnesses, such as those caused by physical trauma, infection, vitamin deficiencies and poisoning.”

The greater health threat now, he said, lies with chronic disease. Six in 10 adults in the United States have a chronic disease; 4 in 10 have two or more. These conditions, such as heart disease, cancer, diabetes, Alzheimer’s and chronic kidney failure, account for 7 out of 10 deaths in the U.S. each year, according to the Centers for Disease Control and Prevention. 

“In the last 70 years, not a single chronic illness is curable using current medical paradigms unless it has a cause that can be bypassed, killed, burned out or cut out,” said Naviaux. 

“When cures are achieved, they rely on recovery by spontaneous healing — an essential process that operates silently in the background and is still poorly understood. Antibiotics can cure a pneumococcal pneumonia and a stent can reopen an occluded (blocked) coronary artery, but active healing is required after the intervention to repair the damaged lung and heart. 

“Without healing,” said Naviaux, “multicellular life on Earth would not exist. Without healing, one injury predisposes to another, leading to disability, chronic disease, accelerated aging and death.”

“In most cases, pathogenesis-based drugs like insulin for diabetes and statins for dyslipidemia (an imbalance of blood lipids, such as cholesterol, that leads to cardiovascular disease) must be taken for life because the root cause of the chronic symptoms is not changed by treatment.”

In his new paper, Naviaux posits that the root cause of many chronic diseases lies with disruption in the normal sequence of mitochondrial transformations needed to initiate and complete the healing cycle.  He has called this universal response to infection, stress, or injury, the cell danger response or CDR. The CDR is an evolutionarily conserved metabolic response that protects cells and hosts from harm. CDR is triggered by exposure to chemical, physical or biological threats. It is a normal part of the immune response that prompts cells to take protective measures.

But sometimes, as Naviaux has shown in past published work, including a ground-breaking preclinical study in 2014, and a seminal Phase 1b/2a Clinical Trial involving young boys with autism published in 2017, CDR continues to sound the alarm even after the originating threat is gone. Inflammation and cell dysfunction persist, resulting in chronic symptoms. 

“Abnormal persistence of any phase of the CDR inhibits the healing cycle, creates dysfunctional cellular mosaics, causes the symptoms of chronic disease and accelerates the process of aging,” said Naviaux. 

“New research reframes the rising tide of chronic disease around the world as a systems problem caused by the combined action of pathogenic triggers and anthropogenic factors (from human activity, such as pollution) that interfere with the mitochondrial functions needed for healing. Once chronic pain, disability or disease is established, salugenesis-based therapies will start where pathogenesis-based therapies end.”

What is Salugenesis?

Salugenesis derives from the Latin word for the Roman goddess of health, safety and prosperity, Salus. It is related to “salutogenesis,” a word coined in 1976 by the medical sociologist Aaron Antonovsky to describe lifestyle choices and coping skills people use to produce, restore and preserve good health despite all manner of hardship. 

Salutogenesis is a sort to big picture concept. Salugenesis is more narrowly focused on the sequential, hard-wired molecular, metabolic and cellular stages of the healing cycle. Both words involve redirecting energy to oppose and reverse the arrow of entropy or decay. They are the opposite of pathogenesis, which is about disorganization and disintegration driven by disease.

Naviaux’s paper makes several key points, among them:

  • Chronic diseases are currently and mistakenly studied in isolation. Diabetes, for example, looks a lot different from post-traumatic stress disorder. But both, and many other conditions, share an underlying failure of the body to fully heal. “Once the pathogenic trigger has been treated or removed, chronic disease persists because healing is incomplete,” said Naviaux.
  • Disease is governed by biological logic, which is intrinsic and the result of millions of years of evolution to address internal problems. Modern medicine has advanced through engineering logic, which looks at external issues generally involving non-living systems.
  • Health and healing are dynamic circles with a beginning, middle and end. The phases are the same whether the injury is a scrape or a stroke. They proceed sequentially by information exchanged between cells and with the environment, directing and informing what happens next. “Mitochondria generate most of the chemical energy needed to power a cell’s biochemical reactions,” said Naviaux. “But they are also cellular canaries in the coal mine, the early warning system that determines the nature and location of a problem or threat, and when to sound the alarm.”
  • Mitochondria naturally prioritize safety and respond to threats of all kinds—from microbial infections, to physical injury, to chemical pollutants in the air, water, and food chain—by stopping their normal anti-inflammatory functions, and shifting to pro-inflammatory functions needed to contain the damage, replace the cells lost, and finally, to restore normal metabolic communication between cells needed for optimum organ function.

CDR is both alarm and the proportional response to threat, he said. If mitochondria do not function properly — or CDR gets stuck in a phase — healing stops and disease prevails.

Curing chronic disease, according to Naviaux, must account for the fact that all such conditions are systems-wide failures, likely caused by multiple factors. “The same disease can be caused by different things in different people,” said Naviaux. Most diseases involve factors such as multiple genes, infection, environmental or microbial exposures, lifestyle choices and more. 

With his work and latest publication, Naviaux argues for development of salugenesis-based research, which would explore the unified biological response to injury, harm and disease. Acute illness, he said, is a temporary state; chronic illness results from the long-term inability to heal completely after an acute injury has passed. They are two sides of the same coin. 

Naviaux said he hopes that new research will lead to a “second book of medicine” that will collect new knowledge about the cause and treatment of complex chronic disease viewed through the lens of the healing cycle and salugenesis. 

“If healing can be rebooted or unblocked after it has been derailed, cures of disorders once thought incurable may one day be possible,” he said.

Common ear, nose, and throat issues in pre-schoolers may be linked to later autism risk

Young children with common ear, nose, and throat (ENT) issues may be at subsequent risk of autism or high levels of demonstrable autism traits, suggests research published online in the open access journal BMJ Open.

Early identification and treatment of ENT conditions may improve these children’s quality of life and potentially help shed light on some of the origins of autism, say the researchers. 

The causes of autism are likely to involve an interplay of genetic, environmental, and biological factors, and the origins of each autistic trait may also differ, note the researchers.

Previous research suggests that ENT conditions, such as ear infections, ‘glue ear’, and sleep disordered breathing, may have a role in the development of autism.  But most of this evidence is based on health records, which may have biased these findings, because parents of children with suspected autism may be more likely than other parents to seek medical help for their offspring, explain the researchers.

To avoid this, the researchers drew on participants in the long term Children of the 90s study, also known as the Avon Longitudinal Study of Parents and Children (ALSPAC). This has tracked the health of more than 14,000 children since birth and that of their parents from the early 1990s onwards.

The current study is based on comprehensive data for more than 10,000 young children who were closely monitored throughout their first 4 years. 

Their mothers completed 3 questionnaires when their children were aged 18, 30, and 42 months, which were designed to record the frequency of 9 different signs and symptoms relating to the ear, nose, and throat as well as any hearing problems.

They also completed 3 questionnaires when their children were just over 3, nearly 6, and 9 years old. These were designed to pinpoint speech coherence, social and communication issues, repetitive and abnormal behaviours, and sociability, traits which are characteristic of autism.  A diagnosis of autism was confirmed from educational records and parental feedback, among other sources.

Adjustments were made for 10 potentially influential ‘environmental’ factors: early or late birth; sex; number of mother’s previous pregnancies resulting in a live or stillbirth; breast feeding; postnatal depression; mother’s educational achievements; mother’s smoking at 18 weeks of pregnancy; mother’s belief in her own agency; child’s exposure to environmental tobacco smoke at 15 months; child’s attendance at a crèche/other daycare by the age of 30 months.

In all, 177 children had a probable diagnosis of autism:139 boys and 38 girls. Those with autism traits were defined as the 10% of the sample with the highest trait scores. 

Early evidence of breathing through the mouth, snoring, ear pulling or poking, reddened and sore ears, worse hearing during a cold, and rarely listening were all more commonly associated with high scores on each of the 4 autism traits, and with a diagnosis of autism.

Pus or sticky discharge from the ears was also associated with autism and with poor coherent speech. 

Among the different ages tested, strong associations were particularly observed when the child was aged 30 and 42 months. Children with high scores on autistic traits at 30 months had more ENT signs. Autism itself was significantly associated with all signs except for symptoms of sleep apnoea  (interrupted breathing during sleep).

Factoring in the 10 environmental features made little difference to the results. For example, children with discharge from their  ears were more than 3 times as likely to have autism, while those with impaired hearing during a cold were more than twice as likely to do so. And children who failed to react to nearby noise were more than 6 times as likely to have autism at this age.

However, the researchers point out: ** “These ENT signs and symptoms are very common in childhood and most children who experience them do not go on to be diagnosed with autism. For example, of the group of around 1700 children who snored at age 30 months, most (1660) weren’t diagnosed with autism later on.” 

The researchers acknowledge various limitations, including the loss of some children to subsequent monitoring, as is the case with any long term study, and the lack of ethnic diversity among the Children of the 90s participants, limiting the wider applicability of the findings.

What’s more, the children weren’t examined consistently to determine a diagnosis of autism; rather, a strategy to assess the probability of a diagnosis using a variety of different sources was used instead.

But they nevertheless conclude that the associations they found “may be important because (1) these ear and respiratory signs may be early markers of increased risk of autism, (2) they may inform the origins of autism, or (3) they may highlight co-occurring conditions that if treated may lead to a better quality of life for children with autism.” 

They add: “This study adds to the evidence that, compared with a typical population of the same age, early ear and upper respiratory symptoms are more common in those subsequently diagnosed with autism or with extreme levels of autistic traits.”

But they caution: “It is not possible to determine whether these ENT conditions have a causal role in the development of autistic traits or are related to an unmeasured factor. 

“One possibility, for example, could be the consequence of the increased prevalence of minor physical anomalies in individuals with autism, including anatomical differences in the structure and/or positioning of the ear, with such differences in ear morphology increasing the risk of ENT conditions.”